Jasmine Rizzo (Sia)
About Jasmine Rizzo (Sia)
Jasmine Rizzo is the Clinical Development Lead for Oncology, Lung at Bristol Myers Squibb, with extensive experience in clinical trial management and regulatory affairs.
Current Role at Bristol Myers Squibb
Jasmine Rizzo serves as the Clinical Development Lead for Oncology, Lung at Bristol Myers Squibb. Her role involves overseeing clinical development strategies and implementing clinical trials to advance lung cancer treatment research.
Career at Bristol Myers Squibb
Jasmine Rizzo has a notable tenure at Bristol Myers Squibb where she has held several roles. Initially, she worked as a Clinical Trial Lead from 2017 to 2020 in New Jersey. She then transitioned to the position of R&D Process Lead for a duration of 10 months in 2020. Following that, she was promoted to her current role as Clinical Development Lead for Oncology, Lung.
Experience at Novartis
From 2016 to 2017, Jasmine worked at Novartis as an Expert Clinical Manager in East Hanover, NJ. She was responsible for managing clinical trials and contributing to oncology research, helping drive forward the company's clinical initiatives in cancer treatment.
Role at Theradex
Between 2014 and 2016, Jasmine served as the Director of Clinical Project Operations at Theradex in Princeton, NJ. In this position, she was responsible for overseeing clinical project management and ensuring the successful execution of clinical trials.
Positions at The Cancer Institute of New Jersey
Jasmine held multiple roles at The Cancer Institute of New Jersey. She was the Interim Director of the Office of Human Research Services from 2013 to 2014, Manager of Clinical Trials Regulatory Affairs from 2010 to 2013, and Program Administrator for the Protocol Review and Monitoring System/Data and Safety Monitoring Committee from 2007 to 2010. These roles allowed her to gain extensive experience in clinical trial management and regulatory affairs.